Author Topic: Debate on changing MS clinical course descriptors  (Read 59 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9664
  • MS diagnosed 1980
  • Location: Pacific Northwest
(MSIF) Pioneering proposal to set new framework for types of MS
« on: December 15, 2022, 09:13:21 am »
This article is getting attention.  This is from "MS Connections," the newsletter of the MS International Federation (December 15, 2022)--"Pioneering proposal for a new framework to describe types of MS":


https://www.msif.org/news/2022/12/14/pioneering-proposal-for-a-new-framework-to-describe-types-of-ms/
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
104 Views
Last post July 02, 2019, 08:39:13 pm
by agate
0 Replies
48 Views
Last post March 10, 2020, 07:57:11 pm
by agate
0 Replies
38 Views
Last post August 15, 2020, 03:42:54 pm
by agate
0 Replies
46 Views
Last post September 16, 2020, 10:12:55 pm
by agate
0 Replies
8 Views
Last post July 05, 2023, 09:48:58 pm
by agate